Host
Beginner's Mind
Blueprints for Builders and Investors
Hosted by Christian Soschner
From pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech—lives or dies by the frameworks it follows.
On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds.
With over 250 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast.
With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:
What it really takes to turn breakthrough science into business—how to grow it, lead it, and shape the world around it.
🎙 Expect each episode to deliver:
- Founder & Investor Blueprints: How breakthrough technologies scale from lab to IPO
- Historical & Biographical Frameworks: Timeless playbooks from the world's great builders
- Leadership & Communication Mastery: Tools to inspire, persuade, and lead at scale
Whether you're building the next biotech success, investing in AI, or leading a climate tech company through hypergrowth—this podcast gives you the edge.
Listen in. Apply what matters. Build companies that last.
📬 Join the newsletter & community: https://lsg2g.substack.com/
Contributors
Guests
Guest
Alasdair Milton
Alasdair Milton, PhD is a Principal at KPMG US and leads the firm’s Precision & Advanced Therapies practice. Based in Boston, he advises global biopharmaceutical companies, investors, and health systems on strategy, commercial due diligence, and the commercialization of cell and gene therapies and precision medicine.
Born on a remote Scottish island with a population of 400, Alasdair was the first in his family to attend university. He earned his Ph.D. in cancer research from the University of Glasgow in 2003 and later built his career in Boston after an early setback when his division was shut down in 2007. He rose rapidly at KPMG, becoming Principal in the firm’s 2024 partner class.
A recognized thought leader, Alasdair speaks at major conferences including BIO and the Milken Institute. He is known for bridging deep science with capital strategy and helping clients navigate the shift from treating disease to proactive, lifelong wellness.